{"id":3183,"date":"2024-02-21T13:13:18","date_gmt":"2024-02-21T13:13:18","guid":{"rendered":"https:\/\/nhsdorset.nhs.uk\/medicines\/?page_id=3183"},"modified":"2024-02-21T13:13:18","modified_gmt":"2024-02-21T13:13:18","slug":"sustainability","status":"publish","type":"page","link":"https:\/\/nhsdorset.nhs.uk\/medicines\/value\/sustainability\/","title":{"rendered":"Sustainability"},"content":{"rendered":"

Green inhalers<\/h2><\/div>

Review of high risk asthma patient<\/h3><\/div>

<\/i><\/i><\/span>What are you asking me to do?<\/span><\/a><\/h4><\/div>
\n

Improve respiratory disease control whilst reducing the carbon footprint of care, in line with new Dorset asthma guidance.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Why are you asking me to do this?<\/span><\/a><\/h4><\/div>
\n

Respiratory illness and inhalers are responsible for a significant proportion of the NHS\u2019 carbon footprint. A healthy environment will benefit the entire community but especially those with respiratory disease.\u00a0\u00a0<\/span><\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>How do I do it?<\/span><\/a><\/h4><\/div>
\n

Run the SystmOne search provided to identify high-risk asthma patients (5+ SABAs in last year).<\/p>\n

Communicate with patients involved and invite them for review.<\/span>\u00a0<\/span><\/p>\n

Review disease control as per Dorset asthma and green respiratory guidance.<\/span>\u00a0<\/span><\/p>\n

Priority should be given to patients with poorly controlled disease and the priority for each interaction should be disease control. This will have the greatest outcome for patients and the environment.<\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>What resources\/support is provided to help me deliver this?<\/span><\/a><\/h4><\/div>
\n

SystmOne searches:<\/p>\n